STEMCELL Technologies Announces Acquisition of Propagenix Inc.

VANCOUVER, British Columbia–(BUSINESS WIRE)–STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Propagenix Inc.—a Maryland-based biotechnology company focused on developing technologies to enable new approaches in regenerative medicine. “The acquisition of Propagenix is an important step in STEMCELL’s growth journey and an achievement for Canada’s biotechnology industry,” said Dr. Allen Eaves, President and CEO, STEMCELL. “Propagenix’s tech

Read More

Business Wire Merger/Acquisition News

Enjoying Merger Arbitrage Limited?

Enjoying Merger Arbitrage Limited?

Sign up then! It's quick and FREE

Have time to share an article? It's very much appreciated!!

You have Successfully Subscribed!